Literature DB >> 33433651

[Personalized treatment concepts for arterial hypertension].

Katharina Lechner1,2, Heribert Schunkert3,4.   

Abstract

Arterial hypertension is the most important risk factor for cardiovascular diseases. Arterial hypertension is diagnosed when reproducible office resting blood pressure values are 140 mm Hg or more systolic and/or 90 mm Hg or more diastolic. A recent alternative is to base the diagnosis of hypertension on ambulatory 24 h blood pressure monitoring (ABPM) and/or home blood pressure monitoring (HBPM) if feasible. Nonpharmacological and pharmacological strategies of blood pressure management are available. Treatment decisions should involve a shared decision-making process and pharmacological agents as well as lifestyle recommendations should be tailored to the needs and comorbidities of each individual patient in a personalized approach. The target values depend on age and comorbidities. Despite clear recommendations as depicted in pertinent guidelines, blood pressure control remains inadequate in the majority of hypertensive patients. The continuous improvement of perception, diagnostics and treatment thus remain high priorities in healthcare systems worldwide. The aim of this CME article is to provide a perspective on recent developments in the management of arterial hypertension.

Entities:  

Keywords:  Antihypertensive agents; Blood pressure; Diagnostics; Nonpharmacological treatment; Personalized prevention

Mesh:

Year:  2021        PMID: 33433651     DOI: 10.1007/s00059-020-05010-1

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  30 in total

1.  [Translating Early Vascular Aging into Clinical Practice].

Authors:  Martin Middeke
Journal:  Dtsch Med Wochenschr       Date:  2019-03-05       Impact factor: 0.628

2.  [Management of arterial hypertension : ESC/ESH guidelines 2018].

Authors:  H Schunkert
Journal:  Herz       Date:  2018-12       Impact factor: 1.443

3.  2018 ESC/ESH Guidelines for the management of arterial hypertension.

Authors:  Bryan Williams; Giuseppe Mancia; Wilko Spiering; Enrico Agabiti Rosei; Michel Azizi; Michel Burnier; Denis L Clement; Antonio Coca; Giovanni de Simone; Anna Dominiczak; Thomas Kahan; Felix Mahfoud; Josep Redon; Luis Ruilope; Alberto Zanchetti; Mary Kerins; Sverre E Kjeldsen; Reinhold Kreutz; Stephane Laurent; Gregory Y H Lip; Richard McManus; Krzysztof Narkiewicz; Frank Ruschitzka; Roland E Schmieder; Evgeny Shlyakhto; Costas Tsioufis; Victor Aboyans; Ileana Desormais
Journal:  Eur Heart J       Date:  2018-09-01       Impact factor: 29.983

4.  Prevention of cardiovascular disease: time for a course correction.

Authors:  Allan D Sniderman; George Thanassoulis; Michael Pencina
Journal:  Eur Heart J       Date:  2020-08-14       Impact factor: 29.983

5.  [Central Aortic Blood Pressure: Important Parameter in Diagnosis and Therapy].

Authors:  Martin Middeke
Journal:  Dtsch Med Wochenschr       Date:  2017-09-22       Impact factor: 0.628

Review 6.  [Management of arterial hypertension].

Authors:  J A Wermelt; H Schunkert
Journal:  Herz       Date:  2017-08       Impact factor: 1.443

7.  Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular Disease.

Authors:  Brian A Ference; Deepak L Bhatt; Alberico L Catapano; Chris J Packard; Ian Graham; Stephen Kaptoge; Thatcher B Ference; Qi Guo; Ulrich Laufs; Christian T Ruff; Arjen Cupido; G Kees Hovingh; John Danesh; Michael V Holmes; George Davey Smith; Kausik K Ray; Stephen J Nicholls; Marc S Sabatine
Journal:  JAMA       Date:  2019-10-08       Impact factor: 56.272

8.  Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factors.

Authors:  Katharina Lechner; Clemens von Schacky; Amy L McKenzie; Nicolai Worm; Uwe Nixdorff; Benjamin Lechner; Nicolle Kränkel; Martin Halle; Ronald M Krauss; Johannes Scherr
Journal:  Eur J Prev Cardiol       Date:  2019-08-13       Impact factor: 7.804

9.  Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countries.

Authors:  Kornelia Kotseva; Guy De Backer; Dirk De Bacquer; Lars Rydén; Arno Hoes; Diederick Grobbee; Aldo Maggioni; Pedro Marques-Vidal; Catriona Jennings; Ana Abreu; Carlos Aguiar; Jolita Badariene; Jan Bruthans; Renata Cifkova; Kairat Davletov; Mirza Dilic; Maryna Dolzhenko; Dan Gaita; Nina Gotcheva; Hosam Hasan-Ali; Piotr Jankowski; Christos Lionis; Silvia Mancas; Davor Milićić; Erkin Mirrakhimov; Rafael Oganov; Nana Pogosova; Željko Reiner; Duško Vulić; David Wood
Journal:  Eur J Prev Cardiol       Date:  2020-03-20       Impact factor: 7.804

10.  May Measurement Month 2019: The Global Blood Pressure Screening Campaign of the International Society of Hypertension.

Authors:  Thomas Beaney; Aletta E Schutte; George S Stergiou; Claudio Borghi; Dylan Burger; Fadi Charchar; Suzie Cro; Alejandro Diaz; Albertino Damasceno; Walter Espeche; Arun Pulikkottil Jose; Nadia Khan; Yoshihiro Kokubo; Anuj Maheshwari; Marcos J Marin; Arun More; Dinesh Neupane; Peter Nilsson; Mansi Patil; Dorairaj Prabhakaran; Agustin Ramirez; Pablo Rodriguez; Markus Schlaich; Ulrike M Steckelings; Maciej Tomaszewski; Thomas Unger; Richard Wainford; Jiguang Wang; Bryan Williams; Neil R Poulter
Journal:  Hypertension       Date:  2020-05-18       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.